Les adipocytokines: lien entre obésité, diabète de type 2 et athérosclérose [Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis]

Details

Serval ID
serval:BIB_E66CD3A2C2FE
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Les adipocytokines: lien entre obésité, diabète de type 2 et athérosclérose [Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis]
Journal
Revue médicale de Liège
Author(s)
Paquot N., Tappy L.
ISSN
0370-629X
Publication state
Published
Issued date
06/2005
Volume
60
Number
5-6
Pages
369-373
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Abstract
Adipose tissue, in addition to the storage of lipids function for lipids, plays active roles in normal metabolic homeostasis and in the development of several diseases, such as type 2 diabetes, dyslipaemia and atherosclerosis. These roles are mediated by adipocytokines, factors secreted by adipose tissue. These include tumor necrosis factors (TNF)-alpha, leptin, resistin, adiponectin or visfatin. Adipocytokines act in an autocrine, paracrine and endocrine manner. Adiponectin is a peculiar adipocytokine because in contrast to the markedly increased levels of leptin, resistin or TNF-alpha in obesity, its level is negatively correlated with body mass index, and is decreased in presence of insulin resistance and in type 2 diabetes. Adiponectin may play a crucial role in the development of diabetes mellitus and high adiponectin levels should protect against impairment of glucose metabolism. Moreover, adipocytokines are involved in the pathogenesis of vascular diseases and may represent a link between obesity, diabetes, inflammation and atherosclerosis. Weight loss, exercise and some antidiabetic drugs also influence plasma adipocytokines levels. For instance, thiazolidinediones treatment in patients with type 2 diabetes resulted in an increased in plasma adiponectin levels and a decrease in circulating TNF-alpha concentrations.
Keywords
Adiponectin, Adipose Tissue/chemistry, Adipose Tissue/physiology, Arteriosclerosis/physiopathology, Cytokines/physiology, Diabetes Mellitus, Type 2/physiopathology, Exercise, Glucose/metabolism, Humans, Insulin Resistance, Intercellular Signaling Peptides and Proteins/physiology, Obesity/complications, Obesity/physiopathology, Weight Loss
Pubmed
Create date
24/01/2008 14:36
Last modification date
20/08/2019 17:09
Usage data